Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

Boehringer Ingelheim Stiftung announces the winner of the 2025 Heinrich Wieland Prize: Adrian R. Krainer of Cold Spring ...

Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA approved assay for solid tumor testing. The test, ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...

A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...

Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...

Moderna (MRNA) stock rises as the company's Spikevax COVID-19 vaccine gets FDA approval for kids 6 months-11 years at higher ...

To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...

To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where they read the genetic instructions from messenger RNA, mRNA, and deliver the ...